CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
Public ClinicalTrials.gov record NCT07322094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CATALINA-4: Phase 1B/2 Study of TORL-1-23 With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Newly Diagnosed Patients With Advanced Stage Ovarian Cancer
Study identification
- NCT ID
- NCT07322094
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- TORL Biotherapeutics, LLC
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Interventions
- TORL-1-23 and paclitaxel Combination Product
- TORL-1-23 and carboplatin Combination Product
- TORL-1-23, paclitaxel, and carboplatin Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 9, 2025
- Primary completion
- Nov 30, 2027
- Completion
- Dec 31, 2027
- Last update posted
- Jul 12, 2026
2025 – 2028
United States locations
- U.S. sites
- 7
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Providence St. Jude Medical Center | Fullerton | California | 92835 | Recruiting |
| City of Hope | Irvine | California | 92618 | Recruiting |
| University of Southern California | Los Angeles | California | 90007 | Recruiting |
| UCLA | Los Angeles | California | 90095 | Recruiting |
| The Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Mt Sinai Hospital | New York | New York | 10029 | Recruiting |
| Duke University | Durham | North Carolina | 27705 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07322094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07322094 live on ClinicalTrials.gov.